A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I)

Hyperimmune globulin (HIG) has shown efficacy against human cytomegalovirus (HCMV) for both transplant and congenital transmission indications. Replicating that activity with a monoclonal antibody (mAb) offers the potential for improved consistency in manufacturing, lower infusion volume, and improv...

Descripción completa

Detalles Bibliográficos
Autores principales: McVoy, Michael M., Tenorio, Edgar, Kauvar, Lawrence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321246/
https://www.ncbi.nlm.nih.gov/pubmed/30544903
http://dx.doi.org/10.3390/ijms19123982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321246/
https://www.ncbi.nlm.nih.gov/pubmed/30544903
http://dx.doi.org/10.3390/ijms19123982

Ejemplares similares